Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents

References

• Miceli M, Atoui R, Thertulien R, et al. Deep septic thrombophlebitis: an unrecognized cause of relapsing bacteremia in patients with cancer. J Clin Oncol 2004; 22: 1529–1531
   PubMedGoogle Scholar
• Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115–125
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ; SENTRY Participants Group. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002; 40: 852–856.
   PubMed Web of Science ®Google Scholar
• Munoz P, Sanchez-Somolinos M, Alcala L, et al. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother 2005; 55: 188–193
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Sobel JD, et al. Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38: 161–189
   PubMed Web of Science ®Google Scholar
• Abbas J, Bodey GP, Hanna HA, et al. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 2000; 160: 2659–2664
   PubMed Web of Science ®Google Scholar
• Mora-Duarte J, Betts R, Rotstein C, et al. Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020–2029
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Rex JH. All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 2002; 34: 600–602
   PubMed Web of Science ®Google Scholar
• Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001; 20: 42–44
   PubMedGoogle Scholar
• Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773–1780
   PubMed Web of Science ®Google Scholar
• Bachmann SP, VandeWalle K, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilm. Antimicrob Agents Chemother 2002; 46: 3591–3596
   PubMed Web of Science ®Google Scholar
• Ramage G, VandeWalle K, Bachmann SP, et al. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002; 46: 3634–3636
   PubMed Web of Science ®Google Scholar
• Sheehan DJ, Hirchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40–79
   PubMed Web of Science ®Google Scholar
• Benoit D, Decruyenaere J, Vandewoude K, et al. Management of candidal thrombophlebitis of the central veins: case report and review. Clin Infect Dis 1998; 26: 393–397
   PubMed Web of Science ®Google Scholar
• Jarret F, Maki DG, Chan CK. Management of septic thrombosis of the inferior vena cava caused by Candida. Arch Surg 1978; 113: 637–639
   PubMedGoogle Scholar
• Seigel EL, Jew AC, Delcore R, Iliopoulos JI, Thomas JH. Thrombolytic therapy for catheter-related thrombosis. Am J Surg 1993; 166: 716–718
   PubMedGoogle Scholar
• Topiel MS, Bryan RT, Kessler CM, Simon GL. Treatment of silastic catheter-induced central vein septic thrombophlebitis. Am J Med Sci 1986; 291: 425–428
   PubMed Web of Science ®Google Scholar
• Yau PC, Norante JD. Thrombophlebitis of the jugular vein secondary to pharyngitis. Arch Otolaryngol 1980; 106: 507–508
   PubMedGoogle Scholar
• Munster AM. Septic thrombophlebitis: A surgical disorder. JAMA 1974; 230: 1010–1011
   PubMedGoogle Scholar
• Verghese A, Widrich WC, Arbeit RD. Central venous thrombophlebitis: the role of medical therapy. Medicine 1985; 64: 394–400
   PubMed Web of Science ®Google Scholar
• Baarslag HJ, van Beek EJ, Koopman MM, Reekers JA. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 2002; 136: 865–872
   PubMed Web of Science ®Google Scholar
• Pollak EW, Walsch J. Subclavian-axillary venous thrombosis: role of non-invasive diagnostic methods. South Med J 1980; 73: 1503–1506
   PubMed Web of Science ®Google Scholar